BOP Members consist of . . .
BOP Meetings held . .
at least quarterly (once every 3 months), conducted by chairman of board (or vice-chairman or member of the board), held in office of the board unless waived by majority
Pharmacist Examinations
Examinations:
- Graduate from ACPE accredited college of pharmacy
- Pass NAPLEX & MPJE with score of at least 75
- Score transfer: per NABP
- If score transfer, can only take MPJE after passing NAPLEX and receiving score
- Not ACPE accredited college:
- Submit application, complete internship requirements, complete NABP FPGEE certification (foreign work experience may be accepted in place of internship)
Examination Repeats:
- Cannot take NAPLEX more than 5 time or MPJE more than 4 consecutive times without passing
- NAPLEX: wait 45 days to retake; MPJE: wait 30 days to retake
Pharmacist Reinstatement exams:
1. Inactive for >1 year - <6 years
2. Inactive for >6 years
Reinstatement exams:
Inactive for >1 year - <6 years:
- Submit renewal, pay past renewal + reinstatement fees, proof of CE for each inactive
renewal period, 60hr internship for each year of inactivity, complete MPJE
- Or complete 60hr internship for each year of inactivity, pass NAPLEX and MPJE
.
Inactive for >6 years: complete 60hr internship for each year of inactivity, pass NAPLEX and MPJE
Pharmacist Reciprocal Licensure:
Reinstatement of reciprocity license:
1. Inactive for >1 year - <6 years
2. Inactive for >6 years
Inactive for >1 year - <6 years:
- Submit renewal, pay past fees, proof of CE for each inactive renewal period, 60hr
internship for each year of inactivity, complete MPJE + submit current letter of good
standing from state of examination
- Or complete 60hr internship for each year of inactivity, pass NAPLEX and pass MPJE
.
Inactive for >6 years: complete 60hr internship for each year of inactivity, pass NAPLEX and MPJE
.
Jurisprudence Exam: must take within 1 year of application; same exam repeat requirements
Pharmacist Temporary license
Pharmacist Unprofessional Conduct Examples:
Pharmacist CE Requirements:
CE Requirements:
- 3.0 CEU (30 contact hours) every 2 years
- 1.0 CEU (10 contact hours) live (excluding law)
- 0.2 CEU (2 contact hours) in patient safety
- 0.2 CEU (2 contact hours) in safe and appropriate use of opioids
- 0.2 CEU (2 contact hours) in pharmacy law
Offered by NM BOP
0.1 CEU (1 hour) by attending one full day of a regularly scheduled NMBOP
meeting or serving on a board approved committee
0.2 CEU (2 hours) by successfully completing an open book test administered by
the board
0.2 CEU (2 hours) pharmacy law programs offered minimum every year in each of
the 5 pharmacy districts
.
- If prescribe vaccines/contraception/naloxone/tobacco cessation: at least 2 hours in each area
- If outside NM: allowed if approved by ACPE
- Inactive status licensees: 1.5 CEU for each year the license was inactive + current CPE to reinstate license
- Audit: no less than 10% of registrants each year (inadequate: fine of $1000 + required to complete CPE)
Consultant Pharmacist
- General Responsibilities:
Consultant Pharmacist: Skilled Nursing Facilities (SNF) and Intermediate Care Facilities (ICF)
.
What are the requirements for customized patient medication packages in SNFs and ICFs?
A: Customized patient medication packages require the consent of the patient, caregiver, prescriber, or institution.
Consultant Pharmacist: Skilled Nursing Facilities (SNF) and Intermediate Care Facilities (ICF).
.
When can a pharmacist repackage patient medication packages?
A: A pharmacist may repackage a patient’s medication package if a drug is added or discontinued from the patient’s drug regimen. Removed drugs must be either destroyed or relabeled and returned to the patient. Drugs cannot be returned to pharmacy stock if they are part of a medication package containing more than one drug.
Consultant Pharmacist: Skilled Nursing Facilities (SNF) and Intermediate Care Facilities (ICF)
A: Customized patient medication packages require the consent of the patient, caregiver, prescriber, or institution.
Consultant Pharmacist: Skilled Nursing Facilities (SNF) and Intermediate Care Facilities (ICF).
.
Q: What are the guidelines for returning patient medication package drugs?
Non-Institutional: Drugs may not be returned to pharmacy stock.
Institutional: Storage and handling of the drugs must be assured. Specific guidelines include:
- Keep the drug in the patient medication package sealed and labeled until dispensed.
- The expiration date of the drug is adjusted to fifty percent of the remaining time.
- Schedule II drugs cannot be returned to inventory.
- Proper record-keeping is required for other scheduled drugs returned to inventory.
Consultant Pharmacist Clinic Reviews: Limited Drug Clinics A-E; what are they? the need for consultant pharmacist? how many sq ft needed?
Consultant Pharmacist: Custodial Care Facilities requirments
Impaired RPh …what does it means/ what needs to be done?
Impaired RPh: unable to safely and competently practice pharmacy due to drug abuse, mental illness, aging, or loss of motor skills
- report to BOP or impaired RPh program
Return and Relabeling Dispensed Drugs:
- Drug left premises: cannot be dispensed or reused again (except in a correctional facility; excluding controlled substances)
- The consultant pharmacist must maintain records at the facility for three years containing the following information if it is returned/ relabled:
Responsibility of
- Pharmacist OR pharmacist intern:
Responsibility of Pharmacists ONLY
Pharmacist only:
- final check on all aspects of the completed prescription
- evaluation of pharmaceuticals for formulary selection within the facility
- supervision of all supportive personnel activities
- ensure that supportive personnel have been properly trained
- any verbal communication with a patient or patient’s representative regarding a change in drug therapy or performing therapeutic interchanges (does not apply to substitution of generic equivalents)
- any other duty required of a pharmacist by any federal or state law.
Patient records: record and maintain at least the following information . . .
Prospective drug review: prior to dispensing any prescription . . .what does it entails ?
Prescription monitoring program (PMP) report for opioid prescriptions:
- The following may indicate abuse:
Opioids from multiple prescribers
Opioid + BZD or carbisopodol
Opioids >12 weeks
>1 analgesic
>90 MME (Per CDC: use caution & carefully reassess individual benefits and
risks w/ ≥50 MME/day; avoid ≥90 MME/day or carefully justify)
Per CDC: recommend naloxone ≥50 MME/day
Overutilization
Early refills
Request to pay cash
Request specific opioid/brand
PMP Review Requirements
Review:
1-year report if any concern about prescription (abuse/misuse concerns,
unfamiliar prescriber/patient, long-acting opioid, opioid + BZD/carisoprodol)
Minimum once every three months during continuous use of opioids for
established patient
Exempt: LTCF or terminal illness